“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executive Tara Comonte in prepared remarks.
More Stories
Short seller Hindenburg alleges Roblox inflated key metrics, and gaming company hits back
Roblox Corp. shares are down 3.3% Tuesday after short seller Hindenburg Research alleged that the online gaming company has inflated...
Harris says ‘it’s about dignity’ as she floats plan for in-home care for seniors
Democratic presidential nominee Kamala Harris on Tuesday proposed a new government benefit, as she remains locked in a tight White...
Nvidia’s stock is closing in on a record. Why Wall Street sees big beats ahead.
Analysts say strong demand for the new Blackwell chip lineup positions Nvidia to deliver strong numbers next year.
This London firm is using Middle Eastern oil money to finance the green transition
The world needs more hydropower to hit its net-zero goals. Here’s how Augusta & Co. is helping to get there.
Here’s how economic issues could help Republicans take back the U.S. Senate
The ouster of the incumbent Democratic senator in Ohio or Montana in November’s election could set the stage for a...
Pfizer’s bondholders cheer news of activist investor Starboard’s $1 billion investment
Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug...